How to predict short-and long-term mortality in patients with pulmonary embolism?

Polskie Archiwum Medycyny Wewnetrznej

Volumn 125, Issue 1-2, 2015, Pages 82-88

  Dentali, Francesco ^a   Cei, Marco ^b   Mumoli, Nicola ^b   Gianni, Monica ^c  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b Livorno Hospital   (Italy)

^c Hospital of Tradate   (Italy)

Author keywords

Long term prognosis; Pulmonary embolism; Shot term prognosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CYSTATIN C; D DIMER; FATTY ACID BINDING PROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TROPONIN; BIOLOGICAL MARKER;

CARDIOVASCULAR DISEASE ASSESSMENT; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ECHOCARDIOGRAPHY; HUMAN; LONG TERM SURVIVAL; LOW RISK PATIENT; LUNG EMBOLISM; MORTALITY; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; PULMONARY EMBOLISM SEVERITY INDEX; REVIEW; RISK FACTOR; SHORT TERM SURVIVAL; BLOOD; FEMALE; MALE; PREDICTIVE VALUE; PULMONARY EMBOLISM; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME FACTOR;

BIOMARKERS; FEMALE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY EMBOLISM; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84924324904     PISSN: 00323772     EISSN: 18979483     Source Type: Journal    
DOI: 10.20452/pamw.2652     Document Type: Review

References (50)

1. Goldhaber SZ. Venous thromboembolism: epidemiology and magnitude of the problem. Best Pract Res Clin Haematol. 2012; 25: 235-242.
2. Cohen AT, Agnelli G, Anderson FA, et al.; VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007; 98: 756-764.
3. DeMonaco NA, Dang Q, Kapoor WN, et al. Pulmonary embolism incidence is increasing with use of spiral computed tomography. Am J Med. 2008; 121: 611-617.
4. Kasper W, Konstantinides S, Geibel A, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol. 1997; 30: 1165-1171.
5. Ng AC, Chung T, Yong AS, et al. Long-term cardiovascular and noncar-diovascular mortality of 1023 patients with confirmed acute pulmonary embolism. Circ Cardiovasc Qual Outcomes. 2011; 4: 122-128.
6. Buller HR, Davidson BL, Decousus H, et al. Subcutaneous fondaparinux versus intra-venous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med. 2003; 349: 1695-1702.
7. Kurkciyan I, Meron G, Sterz F, et al. Pulmonary embolism as a cause of cardiac arrest: presentation and outcome. Arch Intern Med. 2000; 160: 1529-1535.
8. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141 (2 suppl): e419S-e494S.
9. Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2001; 35: 3033-3069.
10. Grifoni S, Olivotto I, Cecchini P, et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocar-diographic right ventricular dysfunction. Circulation. 2000; 101: 2817-2822.
11. Squizzato A, Donadini M P, Galli L, et al. Prognostic clinical prediction rules to identify a low-risk pulmonary embolism: a systematic review and meta-analysis. J Thromb Haemost. 2012; 10: 1276-1290.
12. Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005; 172: 1041-1046.
13. Donzé J, Le Gal G, Fine MJ, et al. Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism. Thromb Haemost. 2008; 100: 943-948.
14. Chan CM, Woods C, Shorr A F. The validation and reproducibility of the pulmonary embolism severity index. J Thromb Haemost. 2010; 8: 1509-1514
15. Nendaz MR, Bandelier P, Aujesky D, et al. Validation of a risk score identifying patients with acute pulmonary embolism, who are at low risk of clinical adverse outcome. Thromb Haemost. 2004; 91: 1232-1236.
16. Jiménez D, Yusen RD, Otero R, et al. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Chest. 2007; 132: 24-30.
17. Aujesky D, Roy PM, Verschuren F, et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet. 2011; 378: 41-48.
18. Jiménez D, Aujesky D, Moores L, et al; RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010; 170: 1383-1389.
19. Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation. 2007; 116: 427-433.
20. Jimenez D, Uresandi F, Otero R, et al. Troponin-based risk stratification of patients with acute non-massive pulmonary embolism: systematic review and meta-analysis. Chest. 2009; 136: 974-982.
21. Klok FA, Mos IC, Huisman MV. Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis. Am J Respir Crit Care Med. 2008; 178: 425-430.
22. Agterof MJ, Schutgens RE, Snijder RJ, et al. Out of hospital treatment of acute pulmonary embolism in patients with a low NT-proBNP level. J Thromb Haemost. 2010; 8: 1235-1241.
23. Puls M, Dellas C, Lankeit M, et al. Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism. Eur Heart J. 2007; 28: 224-229.
24. Kaczynska A, Pelsers MM, Bochowicz A, et al. Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism. Clin Chim Acta. 2006; 371: 117-123.
25. Ruan LB, He L, Zhao S, et al. Prognostic value of plasma heart-type fatty acid-binding protein in patients with acute pulmonary embolism: a meta-analysis. Chest. 2014; 146: 1462-1467.
26. Kostrubiec M, Łabyk A, Pedowska-Włoszek J, et al. Assessment of renal dysfunction improves troponin-based short-term prognosis in patients with acute symptomatic pulmonary embolism. J Thromb Haemost. 2010; 8: 651-658.
27. Kostrubiec M, Łabyk A, Pedowska-Włoszek J, et al. Neutrophil gelati-nase-associated lipocalin, cystatin C and eGFR indicate acute kidney injury and predict prognosis of patients with acute pulmonary embolism. Heart. 2012; 98: 1221-1228.
28. Becattini C, Lignani A, Masotti L, et al. D-dimer for risk stratification in patients with acute pulmonary embolism. J Thromb Thrombolysis. 2012; 33: 48-57
29. Kreit JW. The impact of right ventricular dysfunction on the prognosis and therapy of normotensive patients with pulmonary embolism. Chest. 2004; 125: 1539-1545.
30. Frémont B, Pacouret G, Jacobi D, et al. Prognostic value of echocar-diographic right/left ventricular end-diastolic diameter ratio in patients with acute pulmonary embolism: results from a monocenter registry of 1, 416 patients. Chest. 2008; 133: 358-362.
31. Coutance G, Cauderlier E, Ehtisham J, et al. The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a meta-analysis. Crit Care. 2011; 15: R103.
32. Trujillo-Santos J, den Exter PL, Gómez V, et al. Computed tomography-assessed right ventricular dysfunction and risk stratification of patients with acute non-massive pulmonary embolism: systematic review and meta-anal-ysis. J Thromb Haemost. 2013; 11: 1823-1832.
33. Moores L, Aujesky D, Jiménez D, et al. Pulmonary Embolism Severity Index and troponin testing for the selection of low-risk patients with acute symptomatic pulmonary embolism. J Thromb Haemost. 2010; 8: 517-522.
34. Jiménez D, Kopecna D, Tapson V, et al. On Behalf Of The Protect Investigators. Derivation and validation of multimarker prognostication for normo-tensive patients with acute symptomatic pulmonary embolism. Am J Respir Crit Care Med. 2014; 189: 718-726.
35. Bova C, Sanchez O, Prandoni P, et al. Identification of intermediate-risk patients with acute symptomatic pulmonary embolism. Eur Respir J. 2014; 44: 694-703.
36. Naess IA, Christiansen SC, Romundstad P, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007; 5: 692-699.
37. Reitter SE, Waldhoer T, Mayerhofer M, et al. Long-term survival of patients with a history of venous thromboembolism. Ann Hematol. 2011; 90: 585-594.
38. Heit JA, Silverstein MD, Mohr DN, et al. Pre-dictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med. 1999; 159: 445-453.
39. Schulman S, Lindmarker P, Holmstrom M, et al. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost. 2006; 4: 734-742.
40. Flinterman LE, van Hylckama Vlieg A, et al. Long-term survival in a large cohort of patients with venous thrombosis: incidence and pre-dictors. PLoS Med. 2012; 9: e1001155.
41. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med. 1992; 326: 1240-1245.
42. Ribeiro A, Lindmarker P, Johnsson H, et al. Pulmonary embolism: one-year follow-up with echocardiography Doppler and five-year survival analysis. Circulation. 1999; 99: 1325-1330.
43. Meneveau N, Ming L P, Seronde M F, et al. In-hospital and long-term outcome after sub-massive and massive pulmonary embolism submitted to thrombolytic therapy. Eur Heart J. 2003; 24: 1447-1454.
44. Ng AC, Chow V, Yong AS, et al. Prognostic impact of the Charl-son comorbidity index on mortality following acute pulmonary embolism. Respiration. 2013; 85: 408-416.
45. Janata KM, Leitner JM, Holzer-Richling N, et al.Troponin T predicts in-hospital and 1-year mortality in patients with pulmonary embolism. Eur Respir J. 2009; 34: 1357-1363.
46. Ng AC, Yong AS, Chow V, et al. Cardiac troponin-T and the prediction of acute and long-term mortality after acute pulmonary embolism. Int J Cardiol. 2013; 165: 126-133.
47. Ng AC, Chow V, Yong AS, et al. Fluctuation of serum sodium and its impact on short and long-term mortality following acute pulmonary embolism. PLoS One. 2013; 8: e61966.
48. Subramaniam RM, Mandrekar J, Blair D, et al. The Geneva prognostic score and mortality in patients diagnosed with pulmonary embolism by CT pulmonary angiogram. J Med Imaging Radiat Oncol. 2009; 53: 361-365.
49. Yamaki T, Nozaki M, Sakurai H, et al. Presence of lower limb deep vein thrombosis and prog-nosis in patients with symptomatic pulmonary embolism: preli-minary report. Eur J Vasc Endovasc Surg. 2009; 37: 225-231.
50. Dentali F, Riva N, Turato S, et al. Pulmonary embolism severity index accurately predicts long-term mortality rate in patients hospitalized for acute pulmonary embolism. J Thromb Haemost. 2013; 11: 2103-2310.